Jazz Pharmaceuticals (JAZZ) Operating Margin (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Operating Margin of 31.49% for Q1 2026, up 3772.0% year-over-year from 0.81% in Q1 2025, and up 48.2% quarter-over-quarter from 21.25% in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Operating Margin (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Operating Margin history runs 17 years deep, the most recent figure standing at 31.49% for Q1 2026.
- In Q1 2026, Operating Margin rose 3772.0% year-over-year to 31.49%; the TTM figure through Mar 2026 stood at 0.85% (down 1548.0% YoY), while the FY2025 annual figure was 10.08%, down 2769.0% from the prior year.
- Operating Margin for Q1 2026 stood at 31.49%, up from 21.25% in the prior quarter.
- The five-year high for Operating Margin was 31.49% in Q1 2026, with the low at 65.64% in Q2 2025.
- The 5-year median for Operating Margin is 12.11% (2023), against an average of 6.52%.
- The sharpest annual moves came in 2023 and 2025: Operating Margin soared 3920 bps in 2023, then plunged 8512 bps in 2025.
- Jazz Pharmaceuticals' Operating Margin stood at 27.09% in 2022, then jumped by 145 bps to 12.11% in 2023, then jumped by 45 bps to 17.53% in 2024, then grew by 21 bps to 21.25% in 2025, then jumped by 48 bps to 31.49% in 2026.
- Business Quant data shows JAZZ's Operating Margin at 31.49% in Q1 2026, 21.25% in Q4 2025, and 5.11% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 31.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.06% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -105.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.75% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 17.93% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.36% |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 20.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.54% |
| Mar 31, 2026 | 31.49% |
| Dec 31, 2025 | 21.25% |
| Sep 30, 2025 | 5.11% |
| Jun 30, 2025 | -65.64% |
| Mar 31, 2025 | -6.23% |
| Dec 31, 2024 | 17.53% |
| Sep 30, 2024 | 24.67% |
| Jun 30, 2024 | 19.48% |
| Mar 31, 2024 | 7.34% |
| Dec 31, 2023 | 12.11% |
| Sep 30, 2023 | 17.73% |
| Jun 30, 2023 | 16.47% |
| Mar 31, 2023 | 14.12% |
| Dec 31, 2022 | -27.09% |
| Sep 30, 2022 | 2.63% |
| Jun 30, 2022 | 9.17% |
| Mar 31, 2022 | 10.76% |
| Dec 31, 2021 | 5.51% |
| Sep 30, 2021 | 3.38% |